Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial.
Journal: Hepatology (Baltimore, Md.)
Published: September 09, 2019
Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study.
Journal: Hepatology (Baltimore, Md.)
Published: September 04, 2015
Showing 1-2 of 2
Last Updated: 09/26/2026